CRL 1005

Known as: CRL-1005 
A nonionic block copolymer adjuvant used to enhance viral or non-viral polynucleotide delivery in gene therapy vaccines.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
FALVAC-1A is a second-generation multitarget, multiepitope synthetic candidate vaccine against Plasmodium falciparum… (More)
Is this relevant?
Review
2005
Review
2005
The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • figure I
Is this relevant?
2000
2000
A year ago we described a comparison of 19 immunological adjuvants for their ability to augment antibody and T-cell responses… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
Twenty-five patients with high-risk resected stages IIB, III, and IV melanoma were immunized with a vaccine consisting of the… (More)
  • table 1
  • table 3
  • table 2
  • table 4
  • figure 1
Is this relevant?
1998
1998
The current influenza virus vaccines induce systemic humoral immunity and short lived cellular immunity in young adults… (More)
Is this relevant?
1997
1997
The clinical and immunological effects of a vaccine consisting of CTP37, a synthetic peptide corresponding to the COOH-terminal… (More)
Is this relevant?